The courts are no longer available to them.
In a ruling that redraws the boundary between individual grievance and corporate protection, the Supreme Court has sided with Bayer-Monsanto, extinguishing thousands of lawsuits brought by people who believe the herbicide Roundup gave them cancer. The decision overturns a $1.25 million jury verdict and closes, at least through this legal pathway, the courthouse door to those seeking accountability for their suffering. It is a moment that asks an enduring question: when science is contested and suffering is real, who decides what the law will hear?
- Thousands of cancer patients who spent years waiting for their day in court have had their cases dismissed in a single sweeping ruling.
- The decision overturns a $1.25 million jury verdict, signaling that prior wins for plaintiffs were built on ground the Supreme Court was unwilling to hold.
- Bayer, which absorbed Monsanto and its mounting legal liabilities in 2018, emerges with a decisive shield against mass litigation over glyphosate.
- The ruling aligns judicial authority with federal regulatory approval, raising the bar for any future challenge to government-sanctioned chemicals or products.
- For those who believe Roundup caused their cancer, the legal avenue is now closed — medical bills, lost wages, and a sense of invisibility remain.
On a June morning, the Supreme Court issued a decision that will reshape product liability law in America, siding with Bayer and rejecting thousands of lawsuits from people who claim that exposure to Roundup, the world's most widely used herbicide, caused them to develop cancer. The ruling overturned a $1.25 million verdict awarded to one plaintiff whose case had come to symbolize a broader struggle between individuals seeking accountability and a corporation defending its product.
Roundup's active ingredient, glyphosate, has been applied to American farms, gardens, and roadsides for decades. Beginning in the early 2010s, people who worked with the herbicide or lived near treated fields began filing suit, alleging it caused non-Hodgkin's lymphoma and other cancers. Some cases reached trial, and juries sided with the plaintiffs — verdicts that seemed to signal ordinary Americans believed Roundup was dangerous and that Bayer bore responsibility.
The Supreme Court's decision closed that door. The justices determined the scientific evidence did not support the alleged link between glyphosate and cancer, eliminating not just one verdict but an entire category of pending litigation. People who had waited years for their cases to be heard will now see them dismissed.
The human cost is immediate. Those who believe Roundup harmed them have lost their primary legal avenue for compensation — unable to present evidence, unable to appeal to a jury. For some, unpaid medical bills and lost wages follow. For others, the wound is less tangible: the sense that their suffering has been ruled legally irrelevant.
The ruling carries wider implications as well. By aligning with the EPA's position that glyphosate is safe when used as directed, the Court signaled that federal regulatory approval should constrain what juries are permitted to decide. This reasoning could raise the bar for future product liability cases involving pesticides, pharmaceuticals, and other government-approved chemicals. What the Court has settled is not the science — that remains genuinely contested — but rather the question of what the legal system will allow to be argued. For now, the answer is nothing. The litigation has been halted, and a major corporation has been shielded by the nation's highest court.
On a June morning, the Supreme Court issued a decision that will reshape the landscape of product liability litigation in America. The justices sided with Bayer, the German pharmaceutical and agricultural giant that acquired Monsanto in 2018, rejecting thousands of lawsuits filed by people who claim that exposure to Roundup, the world's most widely used herbicide, caused them to develop cancer. The ruling overturned a $1.25 million verdict that had been awarded to one plaintiff—a man whose legal battle had become emblematic of a much larger struggle between individuals seeking accountability and a corporation defending its product against mounting allegations of harm.
Roundup, which contains the active ingredient glyphosate, has been sprayed on American farms, gardens, and roadsides for decades. It is so ubiquitous that most people have encountered it without thinking much about it. But beginning in the early 2010s, a different narrative began to emerge. People who had worked with the herbicide or lived near fields where it was applied started filing lawsuits, claiming that their exposure had caused non-Hodgkin's lymphoma and other cancers. Some of these cases made it to trial. Juries, hearing testimony from plaintiffs and their medical experts, decided in favor of the claimants. Those verdicts sent a signal: ordinary Americans believed Roundup was dangerous, and they believed Bayer bore responsibility.
But the Supreme Court's decision this week effectively closed the courthouse door to thousands of these claims. The justices determined that the cases should not proceed, backing the company's position that the scientific evidence does not support the link between glyphosate and cancer that plaintiffs were alleging. The decision is sweeping in its scope. It does not merely overturn one verdict; it eliminates an entire category of pending litigation. People who had filed suit, who had waited years for their day in court, who had hoped a jury would hear their story and award them damages—those cases will now be dismissed.
The human cost is immediate and concrete. Individuals who believe Roundup poisoned them have lost their primary legal avenue for seeking compensation. They cannot appeal to a jury. They cannot present evidence of their illness and their exposure. The courts, at least through this pathway, are no longer available to them. For some, this may mean financial hardship; medical bills and lost wages go unpaid. For others, it may mean a deeper wound—the sense that their suffering has been deemed legally irrelevant, that the system has decided their claims are not worth hearing.
The ruling also carries broader implications for how American law treats corporate accountability and chemical safety. Regulatory agencies like the Environmental Protection Agency have maintained that glyphosate is safe when used as directed. The Supreme Court's decision aligns with that regulatory judgment, suggesting that when federal agencies have approved a product, courts should be cautious about allowing juries to second-guess that determination. This reasoning could affect future product liability cases involving pharmaceuticals, pesticides, and other chemicals that have received government approval. It signals that the bar for proving a product is unreasonably dangerous—at least in the eyes of the law—may be higher than some plaintiffs and their advocates had hoped.
Bayer has long maintained that Roundup is safe and that the scientific consensus supports that position. The company has faced enormous legal and financial pressure from these lawsuits, and the Supreme Court decision provides it with a decisive victory. Yet the broader question of whether glyphosate causes cancer remains contested in the scientific community and in the court of public opinion. Some researchers point to studies suggesting a link; others argue the evidence is inconclusive or that any risk is negligible at typical exposure levels. What the Supreme Court has decided is not necessarily what science has settled, but rather what the legal system will permit juries to decide. And for now, that answer is: nothing. The thousands of cases are blocked, the verdicts are overturned, and the litigation that had seemed poised to hold a major corporation accountable has been halted by the nation's highest court.
Notable Quotes
Bayer maintained that Roundup is safe and that the scientific consensus supports that position— Bayer's position in the litigation
The Hearth Conversation Another angle on the story
Why did the Supreme Court block these cases when juries had already sided with the plaintiffs?
The Court decided that federal regulatory approval matters more than jury verdicts. If the EPA says a product is safe, courts shouldn't let juries contradict that judgment.
So the scientific question—does Roundup cause cancer—that's still unsettled?
Completely. Scientists disagree. But the Court wasn't deciding science. It was deciding whether ordinary people get to have their day in court when a federal agency has already blessed the product.
What happens to the people who already won their cases?
Those verdicts are gone. The $1.25 million award is overturned. They lose the money and the validation that a jury gave them.
Is this about Bayer specifically, or something bigger?
It's bigger. This ruling could affect any product that's been federally approved—drugs, chemicals, devices. It raises the wall between regulatory approval and courtroom accountability.
Do people have any other way to seek justice now?
Not really, through the courts. They could petition regulators to revisit the approval, but that's a much slower, less certain path. The legal door has essentially closed.
What does Bayer say about all this?
They've maintained all along that Roundup is safe and that the science supports them. This decision vindicates that position, at least in the eyes of the law.